<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=PRRX1</id>
	<title>PRRX1 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=PRRX1"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=PRRX1&amp;action=history"/>
	<updated>2026-06-27T09:24:18Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=PRRX1&amp;diff=4773&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Paired mesoderm homeobox protein 1 (Homeobox protein PHOX1) (Paired-related homeobox protein 1) (PRX-1) [PMX1]  ==Publications==  {{medline-entry |title=A SIRT1...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=PRRX1&amp;diff=4773&amp;oldid=prev"/>
		<updated>2021-04-29T19:34:18Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Paired mesoderm homeobox protein 1 (Homeobox protein PHOX1) (Paired-related homeobox protein 1) (PRX-1) [PMX1]  ==Publications==  {{medline-entry |title=A SIRT1...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Paired mesoderm homeobox protein 1 (Homeobox protein PHOX1) (Paired-related homeobox protein 1) (PRX-1) [PMX1]&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=A [[SIRT1]]-centered circuitry regulates breast cancer stemness and metastasis.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30038266&lt;br /&gt;
|abstract=Cancer stem cell (CSC)-dictated intratumor heterogeneity accounts for the majority of drug-resistance and distant metastases of breast cancers. Here, we identify a [[SIRT1]]-[[PRRX1]]-[[KLF4]]-ALDH1 circuitry, which couples CSCs, chemo-resistance, metastasis and aging. Pro-longevity protein [[SIRT1]] deacetylates and stabilizes the epithelial-to-mesenchymal-transition (EMT) inducer [[PRRX1]], which inhibits the transcription of core stemness factor [[KLF4]]. Loss of [[SIRT1]] destabilizes [[PRRX1]], disinhibits [[KLF4]], and activates the transcription of ALDH1, which induces and functionally marks CSCs, resulting in chemo-resistance and metastatic relapse. Clinically, the level of [[PRRX1]] is positively linked to [[SIRT1]], whereas [[KLF4]] is reversely correlated. Importantly, [[KLF4]] inhibitor Kenpaullone sensitizes breast cancer cells and xenograft tumors to Paclitaxel and improves therapeutic effects. Our findings delineate a [[SIRT1]]-centered circuitry that regulates CSC origination, and targeting this pathway might be a promising therapeutic strategy.&lt;br /&gt;
|mesh-terms=* Aging&lt;br /&gt;
* Aldehyde Dehydrogenase 1 Family&lt;br /&gt;
* Animals&lt;br /&gt;
* Breast Neoplasms&lt;br /&gt;
* Cell Line, Tumor&lt;br /&gt;
* Drug Resistance, Neoplasm&lt;br /&gt;
* Female&lt;br /&gt;
* Gene Expression Regulation, Neoplastic&lt;br /&gt;
* Homeodomain Proteins&lt;br /&gt;
* Humans&lt;br /&gt;
* Isoenzymes&lt;br /&gt;
* Kruppel-Like Transcription Factors&lt;br /&gt;
* Mice&lt;br /&gt;
* Mice, Nude&lt;br /&gt;
* Neoplasm Invasiveness&lt;br /&gt;
* Neoplastic Stem Cells&lt;br /&gt;
* Retinal Dehydrogenase&lt;br /&gt;
* Signal Transduction&lt;br /&gt;
* Sirtuin 1&lt;br /&gt;
* Xenograft Model Antitumor Assays&lt;br /&gt;
&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283862&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>